NRD
KIDS icon

Nebula Research & Development’s OrthoPediatrics KIDS Stock Holding History

Nebula Research & Development’s Portfolio KIDS Stock Details KIDS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-4,605
Closed -$204K – 397
2023
Q1 		$204K Buy
+4,605
New +$204K 0.36% 174

Other funds holding KIDS

BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
NCGI
Next Century Growth Investors Plymouth, Minnesota $1.38B AUM 102.34% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $71.6B AUM 29.66% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Nebula Research & Development's KIDS Position: Q2 2023 in Review

Nebula Research & Development sold out of OrthoPediatrics (KIDS) in Q2 2023, closing a stake of 4,605 shares — an estimated $204K sold.

Nebula Research & Development first reported a position in KIDS in Q1 2023 and held it in 1 quarter. The position peaked at $204K in Q1 2023. 121 funds tracked by Wall St. Rank hold KIDS as of Q2 2023.

  • Nebula Research & Development reported no remaining OrthoPediatrics position as of Q2 2023 after selling out during the quarter.
  • Nebula Research & Development sold 4,605 OrthoPediatrics shares in Q2 2023, an estimated $204K.
  • Nebula Research & Development first reported a position in OrthoPediatrics in Q1 2023 and held it in 1 quarter.
  • Nebula Research & Development's OrthoPediatrics position peaked at $204K in Q1 2023.
  • 121 funds tracked by Wall St. Rank held OrthoPediatrics as of Q2 2023.

Based on Nebula Research & Development's 13F filing for Q2 2023, filed 14 Aug 2023.